The FDA has approved Enflonsia (clesrovimab-cfor) for the prevention of RSV lower respiratory tract disease in neonates and infants who are born during or entering their first RSV season.

More than 1.7 million window air conditioners are being recalled due to a risk for mold growth, which can lead to serious health problems.

The US Food and Drug Administration says it plans to use artificial intelligence to help speed the approval of new drugs and medical devices.

Cessation of public water fluoridation would increase tooth decay and health system costs in the United States.

Treatment with RBL was effective against recurrent CDI among high-risk patients when administered at home or in clinical settings.

Arakoda ® (tafenoquine) is now available in an 8-count bottle format, according to 60 Degrees Pharmaceuticals. Arakoda, an 8-aminoquinolone antimalarial, was approved in 2018 for the prophylaxis of ...

Influenza- and ARI-associated hospitalization rates in adults were highest in those with underlying medical conditions, but the risk was mediated by influenza vaccination.

For pediatric patients presenting to a hospital, caregiver concern for clinical deterioration is associated with critical illness.

A Texas woman has died after using tap water in a sinus rinse, leading to a rare but often fatal brain infection.

US Health and Human Services Secretary RFK Jr has removed all 17 members of the expert panel that makes US vaccine recommendations.

A 7-day course of antibiotics was noninferior to a 14-day course of antibiotics among patients hospitalized with GN-BSIs.

The risk for MACEs was higher among patients with HIV infection receiving abacavir- vs tenofovir-based ART regimens.